News & Events

HTG Molecular Announces an Amendment and Extension to its Precision Diagnostic Partnership (PDP) Two

TUCSON, Ariz. , Feb. 20, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its second precision diagnostic partnership program (“PDP Two”) with QIAGEN Manchester Limited

full press release

Posted on:

Return To List

Page last updated